SAN DIEGO --(BUSINESS WIRE)--Apr. 16, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019 .

SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,

SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th

SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly

SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.

SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019 .

SAN DIEGO --(BUSINESS WIRE)--Feb. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Manuel Jaime as its new Senior Vice President, Technology and Digital Health .

SAN DIEGO --(BUSINESS WIRE)--Feb. 14, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration ( FDA ) has classified the t:slim X2™ insulin pump as the first in a new device category

SAN DIEGO --(BUSINESS WIRE)--Jan. 21, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019 .

SAN DIEGO --(BUSINESS WIRE)--Jan. 3, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.

SAN DIEGO --(BUSINESS WIRE)--Nov. 13, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff , President and Chief Executive Officer and Leigh Vosseller , EVP and Chief Financial Officer, will present at

SAN DIEGO --(BUSINESS WIRE)--Nov. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it has been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces

SAN DIEGO --(BUSINESS WIRE)--Nov. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13,

SAN DIEGO --(BUSINESS WIRE)--Nov. 1, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018 . Third Quarter 2018 Results In comparing the third quarter of 2018 to

SAN DIEGO --(BUSINESS WIRE)--Oct. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, plans to release its third quarter 2018 results after the financial markets close

SAN DIEGO --(BUSINESS WIRE)--Oct. 12, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has received a Heath Canada Medical Device License

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth SAN DIEGO --(BUSINESS WIRE)--Sep. 25, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--Sep. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced it will host an Institutional Investor and Analyst Day from 8:30am

SAN DIEGO --(BUSINESS WIRE)--Aug. 29, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff , president and CEO, will present a company

SAN DIEGO --(BUSINESS WIRE)--Aug. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™